Santarus financial update

The Cosmo Technologies Ltd. subsidiary of Cosmo Pharmaceuticals S.p.A. (SIX:COPN, Lainate, Italy) sold 4.9 million shares of Santarus stock at $18.25 for $89.2 million in an offering underwritten by Jefferies. As a result of the sale, partner Cosmo's stake in Santarus decreased to 4.6% from 12.2%. The offering includes 637,500 shares sold to Jefferies to cover the overallotment. The offering was proposed May 9, when Santarus' share price was $20.20. Santarus, which closed Friday at $21.91, has 64.6 million shares outstanding. ...